🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06275061
Recruiting Observational

Chinese Obesity and MEtabolic Surgery Database (COMES Database)

NCT06275061 · tracked via the Priya Life Science China tracker
Sponsor
Jinan University Guangzhou
Phase
Observational
Started
2020-05-01
Last updated
2024-02-23

Condition(s) studied

ObesityMetabolic SurgeryBariatric SurgeryWeight Loss

Investigational drug(s) / intervention(s)

Metabolic and Bariatric Surgery

Metabolic and Bariatric Surgery: Metabolic and bariatric surgery is weight loss surgery that results in weight loss and resolution of metabolic disorders.

Study summary

The purpose of the Chinese Obesity and MEtabolic Surgery Database (COMES Database) is to collect data and examine the long-term effects of metabolic and bariatric surgery on obesity and metabolic disorders in the Chinese population.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Patients diagnosed as obesity undergoing metabolic and bariatric surgery. Exclusion Criteria: * Patients treated by non-surgical modalities.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The First Affiliated Hospital of Jinan University Guangzhou Guangdong Recruiting

More Jinan University Guangzhou trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06275061 on ClinicalTrials.gov ↗ ← All trials in China